- Home
- DYN vs PRGS Comparison
DYN vs PRGS Comparison
Compare DYN & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- PRGS
- Stock Information
- Founded
- DYN 1984
- PRGS 1981
- Country
- DYN United States
- PRGS United States
- Employees
- DYN N/A
- PRGS N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- PRGS Computer Software: Prepackaged Software
- Sector
- DYN Health Care
- PRGS Technology
- Exchange
- DYN Nasdaq
- PRGS Nasdaq
- Market Cap
- DYN 1.9B
- PRGS 1.8B
- IPO Year
- DYN 2020
- PRGS 1991
- Fundamental
- Price
- DYN $21.11
- PRGS $40.81
- Analyst Decision
- DYN Strong Buy
- PRGS Strong Buy
- Analyst Count
- DYN 15
- PRGS 5
- Target Price
- DYN $36.53
- PRGS $68.00
- AVG Volume (30 Days)
- DYN 3.2M
- PRGS 573.8K
- Earning Date
- DYN 11-05-2025
- PRGS 09-29-2025
- Dividend Yield
- DYN N/A
- PRGS N/A
- EPS Growth
- DYN N/A
- PRGS N/A
- EPS
- DYN N/A
- PRGS 1.09
- Revenue
- DYN N/A
- PRGS $940,126,000.00
- Revenue This Year
- DYN N/A
- PRGS $32.42
- Revenue Next Year
- DYN N/A
- PRGS $1.44
- P/E Ratio
- DYN N/A
- PRGS $37.16
- Revenue Growth
- DYN N/A
- PRGS 31.41
- 52 Week Low
- DYN $6.36
- PRGS $39.00
- 52 Week High
- DYN $31.32
- PRGS $70.56
- Technical
- Relative Strength Index (RSI)
- DYN 58.23
- PRGS 40.52
- Support Level
- DYN $18.20
- PRGS $39.00
- Resistance Level
- DYN $21.98
- PRGS $43.63
- Average True Range (ATR)
- DYN 1.78
- PRGS 1.13
- MACD
- DYN -0.17
- PRGS -0.21
- Stochastic Oscillator
- DYN 57.30
- PRGS 36.97
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.